PL2788474T3 - Wspólne różnicowanie monocytów od dawców allogenicznych - Google Patents

Wspólne różnicowanie monocytów od dawców allogenicznych

Info

Publication number
PL2788474T3
PL2788474T3 PL13814106T PL13814106T PL2788474T3 PL 2788474 T3 PL2788474 T3 PL 2788474T3 PL 13814106 T PL13814106 T PL 13814106T PL 13814106 T PL13814106 T PL 13814106T PL 2788474 T3 PL2788474 T3 PL 2788474T3
Authority
PL
Poland
Prior art keywords
monocytes
differentiation
allogeneic donors
allogeneic
donors
Prior art date
Application number
PL13814106T
Other languages
English (en)
Inventor
Alex Karlsson-Parra
Bengt Andersson
Original Assignee
Immunicum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunicum Ab filed Critical Immunicum Ab
Publication of PL2788474T3 publication Critical patent/PL2788474T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/40—Nucleotides, nucleosides or bases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2304—Interleukin-4 (IL-4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C12N2506/115—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells from monocytes, from macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13814106T 2012-12-18 2013-12-18 Wspólne różnicowanie monocytów od dawców allogenicznych PL2788474T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12197687 2012-12-18
EP13814106.4A EP2788474B1 (en) 2012-12-18 2013-12-18 Co-differentiation of monocytes from allogeneic donors
PCT/EP2013/077139 WO2014096033A1 (en) 2012-12-18 2013-12-18 Co-differentiation of monocytes from allogeneic donors

Publications (1)

Publication Number Publication Date
PL2788474T3 true PL2788474T3 (pl) 2015-12-31

Family

ID=47427250

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13814106T PL2788474T3 (pl) 2012-12-18 2013-12-18 Wspólne różnicowanie monocytów od dawców allogenicznych
PL15161369.2T PL2913394T3 (pl) 2012-12-18 2013-12-18 Wspólne różnicowanie i aktywowanie monocytów od dawców allogenicznych dla dostarczenia prozapalnych komórek dendrytycznych

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL15161369.2T PL2913394T3 (pl) 2012-12-18 2013-12-18 Wspólne różnicowanie i aktywowanie monocytów od dawców allogenicznych dla dostarczenia prozapalnych komórek dendrytycznych

Country Status (16)

Country Link
US (2) US9714413B2 (pl)
EP (2) EP2913394B1 (pl)
JP (1) JP6529439B2 (pl)
KR (1) KR102148051B1 (pl)
CN (2) CN110042081B (pl)
AU (1) AU2013360793B2 (pl)
BR (1) BR112015014270B1 (pl)
CA (1) CA2895280C (pl)
DK (2) DK2788474T3 (pl)
ES (2) ES2591230T3 (pl)
HU (2) HUE027619T2 (pl)
MX (1) MX357491B (pl)
PL (2) PL2788474T3 (pl)
RU (1) RU2668816C2 (pl)
SI (2) SI2913394T1 (pl)
WO (1) WO2014096033A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2769128T3 (es) 2017-09-20 2020-06-24 Immunicum Ab Células dendríticas alogénicas mejoradas para uso en el tratamiento de cáncer
US12329807B2 (en) 2018-01-18 2025-06-17 Meganano Biotech, Inc. Dead antigen stimulated immature heterogenous dendritic cells as therapeutics for diseases
CN108660125A (zh) * 2018-05-14 2018-10-16 武汉博百欧生物科技有限公司 一种从人体输血废弃物中提取中性粒细胞嗜天青颗粒的方法
US20220106566A1 (en) * 2019-01-22 2022-04-07 The Brigham And Women`S Hospital, Inc. Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010026937A1 (en) * 2000-01-11 2001-10-04 Juha Punnonen Monocyte-derived dendritic cell subsets
WO2003010292A2 (en) * 2001-07-25 2003-02-06 Northwest Biotherapeutics, Inc. Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
DK1509244T3 (da) 2002-06-06 2011-10-24 Immunicum Ab Ny fremgangsmåde og præparat til at producere en cellulær allogen vaccine
KR100585456B1 (ko) * 2003-09-30 2006-06-07 국립암센터 동종 종양-관련 항원이 탑재된 수지상세포, 이의 제조방법및 이를 유효성분으로 하는 암 치료용 백신 조성물
CA2504451A1 (en) * 2004-08-10 2006-02-10 Geron Corporation Dendritic cell vaccines for treating cancer made from embryonic stem cells
KR20080109717A (ko) * 2005-12-08 2008-12-17 노쓰웨스트 바이오써라퓨틱스, 인크. 미성숙 단핵구성 수지상 세포의 활성화를 유도하기 위한조성물 및 방법
EP1806395A1 (en) * 2006-01-06 2007-07-11 Stichting Sanquin Bloedvoorziening Maturation of dendritic cells
EP1840206A1 (en) * 2006-03-28 2007-10-03 Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh Compositions for the preparation of mature dendritic cells
EP2494038B1 (en) * 2009-10-27 2019-06-26 Immunicum AB Method for proliferation of antigen-specific t cells
JP5855018B2 (ja) * 2010-02-10 2016-02-09 イミュニカム アーベー 腫瘍細胞増殖を阻害するための改善された組成物
EP2696894B1 (en) * 2011-04-13 2017-11-01 Immunicum AB Method for priming of t cells
JP2014514927A (ja) * 2011-04-13 2014-06-26 イミュニカム・エイビイ 抗原特異的ｔ細胞の増殖のための方法

Also Published As

Publication number Publication date
DK2788474T3 (en) 2015-09-28
EP2913394B1 (en) 2016-06-22
ES2591230T3 (es) 2016-11-25
CN110042081B (zh) 2023-09-01
PL2913394T3 (pl) 2016-12-30
EP2788474B1 (en) 2015-06-24
RU2015119164A (ru) 2017-01-26
BR112015014270A2 (pt) 2015-11-03
MX357491B (es) 2018-07-11
CA2895280C (en) 2021-04-06
AU2013360793A1 (en) 2015-06-11
WO2014096033A1 (en) 2014-06-26
HUE027619T2 (en) 2016-10-28
US20150329823A1 (en) 2015-11-19
DK2913394T3 (en) 2016-09-19
AU2013360793B2 (en) 2019-01-31
US10626371B2 (en) 2020-04-21
SI2913394T1 (sl) 2017-01-31
CN105452449A (zh) 2016-03-30
CN105452449B (zh) 2019-05-07
CN110042081A (zh) 2019-07-23
KR102148051B1 (ko) 2020-08-25
RU2668816C2 (ru) 2018-10-02
MX2015007800A (es) 2016-01-12
US9714413B2 (en) 2017-07-25
EP2913394A1 (en) 2015-09-02
JP2016501529A (ja) 2016-01-21
KR20150122624A (ko) 2015-11-02
EP2788474A1 (en) 2014-10-15
JP6529439B2 (ja) 2019-06-12
ES2548229T3 (es) 2015-10-15
US20170321189A1 (en) 2017-11-09
HUE028895T2 (en) 2017-02-28
SI2788474T1 (sl) 2016-01-29
CA2895280A1 (en) 2014-06-26
BR112015014270B1 (pt) 2018-12-04

Similar Documents

Publication Publication Date Title
AP3834A (en) Heterocyclyl compounds
ZA201501847B (en) Formulations of enzalutamide
ZA201503594B (en) Pharmaceutical compositions
IL259233A (en) Pharmaceutical preparations containing nitroxyl donors
EP2930509A4 (en) SEPARATION AGENT
PL2887924T3 (pl) Kompozycje farmaceutyczne etorykoksybu
IL219244A0 (en) Splitting of user-lists
SI2788474T1 (sl) Ko-diferenciacija monocitov iz alogenskih darovalcev
SG11201504631WA (en) Feed-through
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
GB201203597D0 (en) Skincare compositions
ZA201503102B (en) Finafloxacin suspension compositions
ZA201407604B (en) Novel depilatory compositions
GB201211153D0 (en) Pharmaceutical compositions
TWM490574U (en) Vibrometer
TWM433525U (en) Structure of calorifier
IL238075A0 (en) pharmaceutical preparations
LT2928896T (lt) Dihidro-pirido-oksazino darinio kieta forma
GB201212028D0 (en) Epit
AU344964S (en) Suspended structure
GB201219234D0 (en) Pharmaceutical compositions
GB201213303D0 (en) Pharmaceutical compositions
GB201204810D0 (en) Pharmaceutical compositions